Besides their vital role in hemostasis and thrombosis, platelets are also recognized to be
involved in cancer, where they play an unexpected central role: They actively influence …

Platelets are essential components in the tumor microenvironment. For decades, clinical
data have demonstrated that cancer patients have a high risk of thrombosis that is …

Objective Preoperative thrombocytosis has been implicated as a negative prognostic marker
for epithelial ovarian cancer (EOC). We assessed whether thrombocytosis is an independent …

Objective To evaluate the influence of preoperative thrombocytosis on survival after surgery
in patients with colorectal cancer (CRC). Methods Four hundred fifty‐three patients who had …

Thrombocytosis is an adverse prognostic factor in many types of cancer. These include
breast cancer, ovarian and other gynecologic cancers, renal cell carcinoma and lung …

Background and aims. Platelets are believed to promote tumor growth and metastasis but
their prognostic role in locally advanced pancreatic cancer (LAPC) remains largely …

Since the first report of the spontaneous appearance of venous thrombophlebitis as a sign of
visceral cancer by Trousseau in 1865, many other studies have documented the existence …

It has been demonstrated recently in several solid tumors that thrombocytosis at diagnosis
may correlate with tumor invasion, metastatic progression and worse outcome. Several …

Increasing evidence is implicating roles for platelets in the development and progression of
ovarian cancer, a highly lethal disease that can arise from the fallopian tubes, and has no …

Although thrombocytosis has been reported in a variety of cancer types, the standard of
thrombocytosis in gastric cancer (GC) and the association between thrombocytosis and the …